Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Response.

Clinical cancer research : an official journal of the American Association for Cancer Research - 14 Mar 2023

Marmouset Vincent, Morice Pierre-Marie, Pagès Arnaud, Leary Alexandra, Micol Jean-Baptiste

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair
Share to Mutation
Share to Neoplasms
Share to Neoplasms, Second Primary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Poly(ADP-ribose) Polymerase Inhibitors

Source

Identifiers

PMID: 36916192
DOI: 10.1158/1078-0432.CCR-23-0164

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapy-related Myeloid Neoplasms Following PARP Inhibitors-Response.PMID 36916192Read ↗

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.Semantic proximity Read ↗

Myeloid malignancies in cancer patients treated with poly(ADP-ribose) polymerase (PARP) inhibitors: a case seriesSemantic proximity Read ↗

Genomics of therapy-related myeloid neoplasmsSemantic proximity Read ↗

Update on rational targeted therapy in AMLSemantic proximity Read ↗

Hematologic complications in patients exposed to PARP inhibitorsSemantic proximity Read ↗

PARP Inhibitors and Myeloid Neoplasms: A Double-Edged SwordSemantic proximity Read ↗

Therapy-related leukemia: is the risk life-long and can we identify patients at greatest risk.Semantic proximity Read ↗

Therapy-related myeloid leukaemia: A model for leukemogenesis in humansSemantic proximity Read ↗

Rapid response to avapritinib of acute myeloid leukemia with t(8;21) andKITmutation relapse post allo-HSCTSemantic proximity Read ↗

An update on PARP inhibitors—moving to the adjuvant settingSemantic proximity Read ↗

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.Semantic proximity Read ↗

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.